tiprankstipranks
Trending News
More News >
Kuros Biosciences Ltd. (CSBTF)
OTHER OTC:CSBTF
US Market

Kuros Biosciences (CSBTF) Income Statement

Compare
13 Followers

Kuros Biosciences Income Statement

Last quarter (Q4 2025), Kuros Biosciences's total revenue was CHF66.04M, an increase of 219.08% from the same quarter last year. In Q4, Kuros Biosciences's net income was CHF3.65M. See Kuros Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
CHF 121.30MCHF 75.56MCHF 33.56MCHF 17.99MCHF 13.81M
Gross Profit
CHF 104.79MCHF 62.03MCHF 23.94MCHF 10.77MCHF 10.07M
Operating Expenses
CHF 97.47MCHF 67.03MCHF 38.09MCHF 24.21MCHF 18.83M
Depreciation and Amortization
CHF 2.80MCHF 2.64MCHF 2.75MCHF 2.83MCHF 2.88M
EBITDA
CHF 10.13MCHF -561.00KCHF -6.84MCHF -8.84MCHF -5.29M
Operating Income
CHF 7.33MCHF -5.00MCHF -13.19MCHF -13.45MCHF -8.77M
Other Income/Expenses
CHF -3.16MCHF 1.65MCHF -155.00KCHF -2.54MCHF -787.00K
Pretax Income
CHF 4.16MCHF -3.35MCHF -9.78MCHF -15.99MCHF -9.55M
Net Income
CHF 2.12MCHF -3.72MCHF -13.73MCHF -14.60MCHF -7.54M
Per Share Metrics
Basic EPS
CHF 0.06CHF -0.10CHF -0.38CHF -0.43CHF -0.23
Diluted EPS
CHF 0.05CHF -0.10CHF -0.38CHF -0.43CHF -0.23
Weighted Average Shares Outstanding
38.44M 37.20M 36.58M 33.90M 32.79M
Weighted Average Shares Outstanding (Diluted)
41.39M 37.20M 36.58M 33.90M 32.79M
Currency in CHF

Kuros Biosciences Earnings and Revenue History